Document is current
Any future updates will be listed below
-
Authors
Park, Bosung
Oh, Eun Hae
Won, Eun Jeong
Kang, Jinseok
Jin, Dasol
Yoo, Chaehwa
Park, Jihoon
Sung, Heungsup
Kim, Mi-Na
-
Funding
Funding for this research was provided by:
Korea Health Technology R&D Project through the Korea Health Industry Development Institute (HI23C0319)
National Research Foundation of Korea (2022R1C1C1002741)
- License Information
-
More Information
Article History
Received: 4 November 2024
Accepted: 10 February 2025
First Online: 13 February 2025
Declarations
:
: Oh EH, Kang J, Jin D, Yoo C, and Park J who were employees of iGENETECH R&D Center developed the MoiM Dx Candida 9-plex assay. These authors were involved in the technical development of the assay and provided expertise on its mechanism of action. However, the study design, data collection, data analysis, interpretation of the results, and manuscript preparation were independently conducted by Park B, Won EJ, Sung H, and Kim MN at Asan Medical Center. The authors declare that these affiliations did not influence the objectivity or integrity of the research.
: This study was approved by the Institutional Review Board (IRB) of Asan Medical Center (approval no. 2023-1186) and was conducted in accordance with relevant guidelines and regulations, including the ethical principles of the Declaration of Helsinki for medical research involving human subjects. The IRB waived the requirement for informed consent.
